92 related articles for article (PubMed ID: 26555799)
21. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
[TBL] [Abstract][Full Text] [Related]
22. A prospective comparative analysis of the accuracy of HistoScanning and multiparametric magnetic resonance imaging in the localization of prostate cancer among men undergoing radical prostatectomy.
Orczyk C; Rosenkrantz AB; Deng FM; Melamed J; Babb J; Wysock J; Kheterpal E; Huang WC; Stifelman M; Lepor H; Taneja SS
Urol Oncol; 2016 Jan; 34(1):3.e1-8. PubMed ID: 26338414
[TBL] [Abstract][Full Text] [Related]
23. Improving the prediction of pathologic outcomes in patients undergoing radical prostatectomy: the value of prostate cancer antigen 3 (PCA3), prostate health index (phi) and sarcosine.
Ferro M; Lucarelli G; Bruzzese D; Perdonà S; Mazzarella C; Perruolo G; Marino A; Cosimato V; Giorgio E; Tagliamonte V; Bottero D; De Cobelli O; Terracciano D
Anticancer Res; 2015 Feb; 35(2):1017-23. PubMed ID: 25667489
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of apparent diffusion coefficient and MR volumetry as independent associative factors for extra-prostatic extension (EPE) in prostatic carcinoma.
Lim C; Flood TA; Hakim SW; Shabana WM; Quon JS; El-Khodary M; Thornhill RE; El Hallani S; Schieda N
J Magn Reson Imaging; 2016 Mar; 43(3):726-36. PubMed ID: 26303719
[TBL] [Abstract][Full Text] [Related]
25. Value of power Doppler sonography with 3D reconstruction in preoperative diagnostics of extraprostatic tumor extension in clinically localized prostate cancer.
Zalesky M; Urban M; Smerhovský Z; Zachoval R; Lukes M; Heracek J
Int J Urol; 2008 Jan; 15(1):68-75; discussion 75. PubMed ID: 18184177
[TBL] [Abstract][Full Text] [Related]
26. Transperineal versus transrectal prostate biopsy for predicting the final laterality of prostate cancer: are they reliable enough to select patients for focal therapy? Results from a multicenter international study.
Miano R; De Nunzio C; Kim FJ; Rocco B; Gontero P; Vicentini C; Micali S; Oderda M; Masciovecchio S; Asimakopoulos AD
Int Braz J Urol; 2014; 40(1):16-22. PubMed ID: 24642146
[TBL] [Abstract][Full Text] [Related]
27. Can saturation biopsy predict prostate cancer localization in radical prostatectomy specimens: a correlative study and implications for focal therapy.
Falzarano SM; Zhou M; Hernandez AV; Moussa AS; Jones JS; Magi-Galluzzi C
Urology; 2010 Sep; 76(3):682-7. PubMed ID: 20206973
[TBL] [Abstract][Full Text] [Related]
28. When to perform bone scan in patients with newly diagnosed prostate cancer: external validation of the currently available guidelines and proposal of a novel risk stratification tool.
Briganti A; Passoni N; Ferrari M; Capitanio U; Suardi N; Gallina A; Da Pozzo LF; Picchio M; Di Girolamo V; Salonia A; Gianolli L; Messa C; Rigatti P; Montorsi F
Eur Urol; 2010 Apr; 57(4):551-8. PubMed ID: 20034730
[TBL] [Abstract][Full Text] [Related]
29. Can the conventional sextant prostate biopsy accurately predict unilateral prostate cancer in low-risk, localized, prostate cancer?
Mayes JM; Mouraviev V; Sun L; Tsivian M; Madden JF; Polascik TJ
Urol Oncol; 2011; 29(2):166-70. PubMed ID: 19451000
[TBL] [Abstract][Full Text] [Related]
30. The utility of PSA velocity in prediction of prostate cancer and high grade cancer after an initially negative prostate biopsy.
Elshafei A; Li YH; Hatem A; Moussa AS; Ethan V; Krishnan N; Li J; Jones JS
Prostate; 2013 Dec; 73(16):1796-802. PubMed ID: 24038200
[TBL] [Abstract][Full Text] [Related]
31. Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry.
Veltri RW; Miller MC; Isharwal S; Marlow C; Makarov DV; Partin AW
Cancer Epidemiol Biomarkers Prev; 2008 Jan; 17(1):102-10. PubMed ID: 18199716
[TBL] [Abstract][Full Text] [Related]
32. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy.
Singh H; Canto EI; Shariat SF; Kadmon D; Miles BJ; Wheeler TM; Slawin KM
J Urol; 2004 Jan; 171(1):204-9. PubMed ID: 14665877
[TBL] [Abstract][Full Text] [Related]
33. Prostate-specific antigen vs prostate-specific antigen density as a predictor of upgrading in men diagnosed with Gleason 6 prostate cancer by contemporary multicore prostate biopsy.
Oh JJ; Hong SK; Lee JK; Lee BK; Lee S; Kwon OS; Byun SS; Lee SE
BJU Int; 2012 Dec; 110(11 Pt B):E494-9. PubMed ID: 22540236
[TBL] [Abstract][Full Text] [Related]
34. Can biopsy be a reliable predictor of spatial distribution of prostate cancer? Comparison of a novel biopsy regimen with radical prostatectomy findings.
Introini C; Naselli A; Vigliercio G; Spina B; Truini M; Puppo P
Urology; 2006 Dec; 68(6):1301-4. PubMed ID: 17169650
[TBL] [Abstract][Full Text] [Related]
35. MR-guided prostate biopsy for planning of focal salvage after radiation therapy.
Ménard C; Iupati D; Publicover J; Lee J; Abed J; O'Leary G; Simeonov A; Foltz WD; Milosevic M; Catton C; Morton G; Bristow R; Bayley A; Atenafu EG; Evans AJ; Jaffray DA; Chung P; Brock KK; Haider MA
Radiology; 2015 Jan; 274(1):181-91. PubMed ID: 25203127
[TBL] [Abstract][Full Text] [Related]
36. Preoperative neural network using combined magnetic resonance imaging variables, prostate-specific antigen, and Gleason score to predict positive surgical margins.
Poulakis V; Witzsch U; de Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
Urology; 2004 Sep; 64(3):516-21. PubMed ID: 15351582
[TBL] [Abstract][Full Text] [Related]
37. Role of dynamic contrast-enhanced magnetic resonance (MR) imaging and proton MR spectroscopic imaging in the detection of local recurrence after radical prostatectomy for prostate cancer.
Sciarra A; Panebianco V; Salciccia S; Osimani M; Lisi D; Ciccariello M; Passariello R; Di Silverio F; Gentile V
Eur Urol; 2008 Sep; 54(3):589-600. PubMed ID: 18226441
[TBL] [Abstract][Full Text] [Related]
38. Combination and multivariate analysis of PSA-based parameters for prostate cancer prediction.
Djavan B; Remzi M; Zlotta AR; Seitz C; Wolfram R; Hruby S; Bursa B; Schulman CC; Marberger M
Tech Urol; 1999 Jun; 5(2):71-6. PubMed ID: 10458658
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of prostate cancer detection with ultrasound real-time elastography: a comparison with step section pathological analysis after radical prostatectomy.
Salomon G; Köllerman J; Thederan I; Chun FK; Budäus L; Schlomm T; Isbarn H; Heinzer H; Huland H; Graefen M
Eur Urol; 2008 Dec; 54(6):1354-62. PubMed ID: 18374470
[TBL] [Abstract][Full Text] [Related]
40. Is prostate-specific antigen velocity selective for clinically significant prostate cancer in screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam).
Wolters T; Roobol MJ; Bangma CH; Schröder FH
Eur Urol; 2009 Feb; 55(2):385-92. PubMed ID: 18353529
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
